Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | ADK | P55263 | 1/20 | 0.50 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.50 |
| ▸ | CFTR | P13569 | 1/20 | 0.45 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.41 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.39 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.39 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.39 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7579076 | 0.91 | NISCH (0.52) | SLC6A2SLC6A4SLC6A3MTORADK | |
| SCHEMBL3278270 | 0.82 | MTOR (0.46) | SLC6A2SLC6A4SLC6A3MTORADK | |
| SCHEMBL4729372 | 0.82 | MTOR (0.48) | SLC6A2SLC6A4SLC6A3MTORADK | |
| SCHEMBL2205006 | 0.80 | F2RL1 (0.48) | MTORADKNISCHADRA2AADRA2B | |
| SCHEMBL698729 | 0.80 | ADRA2A (0.60) | SLC6A2SLC6A4SLC6A3MTORADK | |
| SCHEMBL8201456 | 0.80 | MTOR (0.47) | SLC6A2SLC6A4SLC6A3MTORADK | |
| SCHEMBL4363951 | 0.80 | MTOR (0.47) | SLC6A2SLC6A4SLC6A3MTORADK | |
| SCHEMBL10642682 | 0.80 | F2RL1 (0.42) | F2RL1 | |
| SCHEMBL28000044 | 0.80 | ADRA2A (0.60) | SLC6A2SLC6A4SLC6A3MTORADK | |
| SCHEMBL8700070 | 0.80 | MTOR (0.47) | SLC6A2SLC6A4SLC6A3MTORADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116034089-A | EMM-58 zeolite compositions, synthesis and uses | 埃克森美孚技术与工程公司 | 2023-04-28 | — | — | CN | claimed |
| CN-114479795-A | Expanded particle composite water shutoff agent, preparation method thereof and water shutoff construction method | 中国石油化工股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-110003869-B | Crack plugging agent based on expanded particles and curable particles | 西南石油大学 | 2021-04-06 | — | — | CN | claimed |
| US-20050261328-A1 | Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-24 | — | — | US | claimed |
| EP-1567149-A2 | PHARMACEUTICAL COMPOSITION COMPRISING BETA-3-ADRENOCEPTOR AGONISTS AND ANTIMUSCARINIC AGENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-08-31 | — | — | EP | claimed |
| WO-2004047838-A2 | PHARMACEUTICAL COMPOSITION COMPRISING BETA-3-ADRENOCEPTOR AGONISTS AND ANTIMUSCARINIC AGENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-06-10 | — | — | WO | claimed |
| EP-0003796-B1 | SUBSTITUTED DIPHENYLMETHYL-IMIDAZOLES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | BAYER AG (DE) | 1980-10-15 | — | — | EP | claimed |
| EP-0003796-A1 | Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them | BAYER AG (DE) | 1979-09-05 | — | — | EP | claimed |
| JP-62205002-A | — | — | None | — | — | JP | disclosed |
| JP-5078328-A | — | — | None | — | — | JP | disclosed |
| CN-119731728-A | Luminescent material, light emitting diode and display device | 京东方科技集团股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-3365819-B1 | PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 | MANGOSUTHU UNIV OF TECHNOLOGY (ZA) | 2023-06-07 | — | — | EP | disclosed |
| CN-116034089-A | EMM-58 zeolite compositions, synthesis and uses | 埃克森美孚技术与工程公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-114479795-A | Expanded particle composite water shutoff agent, preparation method thereof and water shutoff construction method | 中国石油化工股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| EP-0003796-B1 | SUBSTITUTED DIPHENYLMETHYL-IMIDAZOLES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | BAYER AG (DE) | 1980-10-15 | — | — | EP | disclosed |
| US-4182624-A | FUNGICIDES, HERBICIDES, PLANT GROWTH REGULATORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-01-08 | — | — | US | disclosed |
| US-4182624-A | FUNGICIDES, HERBICIDES, PLANT GROWTH REGULATORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-01-08 | — | — | US | disclosed |
| EP-0003796-A1 | Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them | BAYER AG (DE) | 1979-09-05 | — | — | EP | disclosed |
| EP-0003796-A1 | Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them | BAYER AG (DE) | 1979-09-05 | — | — | EP | disclosed |
| EP-0003796-A1 | Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them | BAYER AG (DE) | 1979-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261328-A1 | Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents | ADRB3, ADRB2, ADRB1 | SLC6A2 381/4885SLC6A4 1183/4885SLC6A3 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.